Abstract
We aimed to evaluate clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cell (UCMSC) transplantation in the treatment of end-stage liver diseases. The human UCMSCs were cultured and prepared, and then transplanted into the hepatic tissues of 50 patients with decompensated cirrhosis. The liver function, thrombin function, Model for End-Stage Liver Disease (MELD) score, and hemodynamic index value were detected during a 24-week follow-up period, with the addition of hepatoprotective, antiviral, and other conventional treatments. No complications or serious side effects were observed. In the first 2-3 weeks after surgery, symptoms including abdominal distension, oliguria, edema, and others decreased significantly, with increased appetite compared with before surgery. In the 24-week follow-up period, the levels of serum albumin and prealbumin increased significantly compared with the preoperative levels; the decrease of coagulation indicators was not significant. The MELD scores were also markedly increased. Alpha-fetoprotein levels increased without significance after treatment. There was no significant difference in the hemodynamic changes in the portal and splenic veins according to ultrasound. Moreove...Continue Reading
References
Dec 13, 2002·Gut·F BottaR Testa
Dec 31, 2002·Blood·Mauro KramperaFrancesco Dazzi
Nov 18, 2004·American Journal of Surgery·Neil FarnsworthSamir S Awad
Dec 8, 2004·Stem Cells·Hwai-Shi WangChin-Chang Chen
Jul 29, 2005·The American Journal of Pathology·Amar Deep SharmaMichael Ott
Jan 10, 2006·Lancet·David A Leon, Jim McCambridge
Feb 17, 2006·The New England Journal of Medicine·Victor J Navarro, John R Senior
Jun 17, 2006·Stem Cells·Shuji TeraiIsao Sakaida
Oct 21, 2006·Stem Cells·Sercin KarahuseyinogluAlp Can
Mar 22, 2007·World Journal of Gastroenterology : WJG·Andre Castro LyraLuiz Guilherme Costa Lyra
Oct 3, 2007·Blood·Patricia S ChoChristene A Huang
Mar 11, 2008·Lancet·Detlef Schuppan, Nezam H Afdhal
May 21, 2009·European Journal of Gastroenterology & Hepatology·Pedram KharazihaMasoud Soleimani
Mar 30, 2010·Cytotherapy·Chiyo DoiMasaaki Tamura
Sep 22, 2010·Pediatric Surgery International·Shilpa SharmaDevendra K Gupta
May 25, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Liang PengZhi-liang Gao
Jun 7, 2011·The American Journal of the Medical Sciences·Ling-Ling ShiDe-Wen Wang
Oct 19, 2011·Cellular Immunology·Changhui ZhouFangxia Guan
Feb 15, 2012·Journal of Gastroenterology and Hepatology·Zheng ZhangFu-Sheng Wang
Jul 14, 2012·BMC Gastroenterology·Patrizia BurraFrancesco Paolo Russo
Dec 1, 2012·Stem Cells Translational Medicine·Ming ShiFu-Sheng Wang
Dec 6, 2012·Thorax·Maria PierroBernard Thébaud
Jun 4, 2013·International Journal of Molecular Sciences·Dae-Won KimCesar V Borlongan
Jul 31, 2013·Coronary Artery Disease·Wei ZhangHai-Yan Zhang
Oct 12, 2013·Cell Biology International·Kyoung-Won SeoHwa-Young Youn
Nov 16, 2013·Cell Death & Disease·L CuiY Han
Mar 8, 2014·World Journal of Gastroenterology : WJG·Byoung-Jin ParkHye-Ree Lee
Citations
Feb 1, 2017·Cell and Tissue Banking·Yan HeLinyao Fu
Jan 13, 2019·Journal of Cellular and Molecular Medicine·Chenxia HuLanjuan Li
Feb 15, 2020·Stem Cell Research & Therapy·Minmin HouXiaoli Liu
Nov 22, 2018·Medicine·Kai MuHongmei Wang
Jan 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Lu WangWei-Hong Kuang
Dec 31, 2020·Genes·Paz de la Torre, Ana I Flores
Mar 8, 2019·ACS Nano·Hongmei CaoYuebing Wang